IPO Trending
AGARWALEYEEQ / NSE, BSEListed

Dr. Agarwals Health Care Limited

Dr. Agarwal’s Health Care Limited, founded on April 19, 2010, is a leading eye care provider in India. Based in Chennai, Tamil Nadu, the company runs one of the largest networks of eye hospitals both in India and internationally. They specialize in advanced eye care services like cataract surgeries, retinal treatments, refractive surgeries, corneal transplants, glaucoma management, and pediatric eye care. Known for using the latest technologies and innovative surgical methods, the company is trusted by patients for its high-quality care. Dr. Agarwal’s also offers customized treatments for complex eye conditions and has a team of highly skilled ophthalmologists and staff to ensure the best results. They are committed to constantly improving by investing in new medical technologies and training programs. As of March 31, 2024, the company has expanded globally and employs over 1,000 professionals, including doctors, researchers, and administrative staff, all working towards making top-notch eye care accessible and affordable for everyone.

₹382 - ₹4021.55x sub
Listed Price402.00
Listing Gain+0.00%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Sep-24)838 Cr
Growth+17.4%
Revenue Trend (₹ in Crores)
0.0527.51.1k1.6kMar-22Mar-23Mar-24Sep-24
PeriodRev (Cr)PAT (Cr)AssetsDebt
Sep-24838403,393374
Mar-241,376952,753388
Mar-231,0311031,825356
Mar-22714431,026290
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Sep-2412.69%8.30%0160.48
Mar-243.139.33%14.61%130.440
Mar-23423.12%15.18%00